Maria Drayss

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pulmonary Artery

Magnetic Resonance Imaging

Low Birth Weight

Top Venues

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Gülmisal Güder, Theresa Reiter, Maria Drayss, Wolfgang Rudolf Bauer, Björn Lengenfelder, Peter Nordbeck, Georg Fette, Stefan Frantz, Caroline Morbach, Stefan Stoerk
Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry-A Cardiac Magnetic Resonance Imaging Study. Journal of cardiovascular development and disease 11 (6) (2024)
Gülmisal Güder, Theresa Reiter, Maria Drayss, Wolfgang Rudolf Bauer, Björn Lengenfelder, Peter Nordbeck, Georg Fette, Stefan Frantz, Caroline Morbach, Stefan Stoerk
Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry-A Cardiac Magnetic Resonance Imaging Study. Journal of cardiovascular development and disease 11 (6) (2024)
Gülmisal Güder, Theresa Reiter, Maria Drayss, Wolfgang Rudolf Bauer, Björn Lengenfelder, Peter Nordbeck, Georg Fette, Stefan Frantz, Caroline Morbach, Stefan Stoerk
Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry-A Cardiac Magnetic Resonance Imaging Study. Journal of cardiovascular development and disease 11 (6) (2024)
Lukas Johannes Weiss, Maria Drayss, Kristina Mott, Sarah Beck, David Unsin, Bastian Just, Christian P Speer, Christoph Härtel, Oliver Andres, Harald Schulze
Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: The PLINIUS study. Blood advances (2023)
Lukas Johannes Weiss, Maria Drayss, Georgi Manukjan, Maximilian Josef Zeitlhöefler, Judith Kleiss, Mathis Leonard Weigel, Johannes Herrmann, Kristina Mott, Sarah Beck, Philipp Burkard, Thien-Tri Lam, Karina Althaus, Tamam Bakchoul, Stefan Frantz, Patrick Meybohm, Bernhard Nieswandt, Dirk Weismann, Harald Schulze
Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as therapeutic target in COVID-19. Blood advances (2022)